{"anticipatedPostingDate":"2011-08","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"}],"units":"Participants"}],"description":"Number of patients who were free of disease and alive at 1 year.","groups":[{"description":"Patients receive administration of high dose cytosine arabinoside and mitoxantrone followed by hematopoietic cell transplant.","id":"OG000","title":"Cytarabine + Mitoxantrone"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"1 year","title":"Disease-free Survival","type":"PRIMARY","unitOfMeasure":"Participants"}